LeMaitre Vascular, Inc. (LMAT)
80.67
+0.18
(+0.22%)
USD |
NASDAQ |
Sep 04, 16:00
80.71
+0.04
(+0.05%)
After-Hours: 20:00
LeMaitre Vascular Shareholders Equity (Quarterly) : 420.34M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 420.34M |
| March 31, 2026 | 406.62M |
| December 31, 2025 | 393.52M |
| September 30, 2025 | 378.92M |
| June 30, 2025 | 362.69M |
| March 31, 2025 | 347.57M |
| December 31, 2024 | 337.29M |
| September 30, 2024 | 331.07M |
| June 30, 2024 | 319.53M |
| March 31, 2024 | 308.50M |
| December 31, 2023 | 297.90M |
| September 30, 2023 | 288.64M |
| June 30, 2023 | 283.83M |
| March 31, 2023 | 274.16M |
| December 31, 2022 | 268.20M |
| September 30, 2022 | 261.25M |
| June 30, 2022 | 258.03M |
| March 31, 2022 | 257.79M |
| December 31, 2021 | 254.15M |
| September 30, 2021 | 249.05M |
| June 30, 2021 | 185.83M |
| March 31, 2021 | 177.52M |
| December 31, 2020 | 172.57M |
| September 30, 2020 | 160.98M |
| June 30, 2020 | 152.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 148.84M |
| December 31, 2019 | 148.14M |
| September 30, 2019 | 142.32M |
| June 30, 2019 | 137.54M |
| March 31, 2019 | 133.09M |
| December 31, 2018 | 130.24M |
| September 30, 2018 | 125.35M |
| June 30, 2018 | 120.74M |
| March 31, 2018 | 113.47M |
| December 31, 2017 | 109.77M |
| September 30, 2017 | 106.11M |
| June 30, 2017 | 98.31M |
| March 31, 2017 | 91.62M |
| December 31, 2016 | 87.50M |
| September 30, 2016 | 86.69M |
| June 30, 2016 | 82.85M |
| March 31, 2016 | 80.62M |
| December 31, 2015 | 77.88M |
| September 30, 2015 | 74.19M |
| June 30, 2015 | 70.44M |
| March 31, 2015 | 67.93M |
| December 31, 2014 | 68.21M |
| September 30, 2014 | 67.12M |
| June 30, 2014 | 67.78M |
| March 31, 2014 | 56.24M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.93B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 640.55M |
| Total Liabilities (Quarterly) | 220.21M |
| Debt to Equity Ratio | 0.4526 |
| Current Ratio | 15.89 |
| Net Debt Paydown Yield | -0.04% |